Kathryn E. Falberg
2012
In 2012, Kathryn E. Falberg earned a total compensation of $4.1M as Former Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals, a 195% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $390,000 |
|---|---|
| Option Awards | $1,619,569 |
| Salary | $446,769 |
| Stock Awards | $1,639,047 |
| Other | $2,622 |
| Total | $4,098,007 |
Falberg received $1.6M in stock awards, accounting for 40% of the total pay in 2012.
Falberg also received $390K in non-equity incentive plan, $1.6M in option awards, $446.8K in salary and $2.6K in other compensation.
Rankings
In 2012, Kathryn E. Falberg's compensation ranked 1,598th out of 11,487 executives tracked by ExecPay. In other words, Falberg earned more than 86.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,598 out of 11,487 | 86th |
Division Manufacturing | 570 out of 4,253 | 87th |
Major group Chemicals And Allied Products | 124 out of 1,203 | 90th |
Industry group Drugs | 66 out of 925 | 93rd |
Industry Pharmaceutical Preparations | 56 out of 700 | 92nd |
Source: SEC filing on June 10, 2015.
Falberg's colleagues
We found four more compensation records of executives who worked with Kathryn E. Falberg at Jazz Pharmaceuticals in 2012.